NON-COMMUNICABLE DISEASE SYNDEMICS AMONG LOW-INCOME POPULATIONS: PAKISTAN AND WAY FORWARD
DOI:
https://doi.org/10.59058/jaimc.v20i4.80Keywords:
non-communicable, Pakistan, Syndemics, low incomeAbstract
Non-communicable diseases (NCDs) have substantially contributed to morbidity and mortality of populations. The emergence of the novel coronavirus SARS-CoV2 pandemic took centre stage toppling over the global health and economies leading to high morbidity and mortality rates. Presently as many as one in five with underlying NCDs are at risk of severe Covid-19[3].In May 2020, the World Health Organization (WHO) undertook a fast evaluation survey, which revealed that 75% of nations have experienced service outages related to NCDs. Public health campaigns and NCD surveillance programmes were among the hardest damaged. Gains against COVID-19 are hollow wins when the risky interactions between NCDs and virus infection are not perceived as syndemics along with social and economic disparities.
References
Abbafati C, Abbas KM, Abbasi M, Abbasifard M, Akinyemiju T, Akombi B, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: A systematic analysis for the global burden of disease study 2019. The Lancet. 2020Oct17;396(10258):1204–22.
Non communicable diseases [Internet]. World Health Organization. World Health Organization; 2022 [cited 2023Feb10]. Available from: https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases
The Lancet. Covid-19: A new lens for non-communicable diseases. The Lancet. 2020Sep5;396(10252):649.
Bukhman G, Mocumbi AO, Atun R, Becker AE, Bhutta Z, Binagwaho A, et al. The Lancet NCDI Poverty Commission: Bridging a gap in universal health coverage for the poorest billion. The Lancet. 2020Sep14;396(10256):991–1044.
Non communicable diseases [Internet]. World Health Organization. World Health Organization; 2022 [cited 2023Feb10]. Available from: https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases
Wang H, Abbas KM, Abbasifard M, Abbasi-Kangevari M, Abbastabar H, Abd-Allah F, et al. Global age-sex-specific fertility, mortality, healthy life expectancy (Hale), and population estimates in 204 countries and territories, 1950–2019: A comprehensive demographic analysis for the global burden of disease study 2019. The Lancet. 2020;396(10258):1160–203. DOI:https://doi.org/10.1016/S0140-6736(20)30977-6
Micah AE, Cogswell IE, Cunningham B, Ezoe S, Harle AC, Maddison ER, et al. Tracking development assistance for health and for covid-19: A review of development assistance, government, out-of-pocket, and other private spending on health for 204 countries and territories, 1990–2050. The Lancet. 2021Sep12;398(10308):1317–43. DOI:https://doi.org/10.1016/S0140-6736(21)01258-7
Hafeez A, Dangel WJ, Ostroff SM, Kiani AG, Glenn SD, Abbas J, et al. The State of Health in Pakistan and its provinces and Territories, 1990–2019: A systematic analysis for the global burden of disease study 2019. The Lancet Global Health. 2023Feb;11(2). DOI:https://doi.org/10.1016/S2214-109X(22)00497-1
Hassan M, Butt ZA. Cancer research in Pakistan: Opportunities, challenges and the way forward. J.Cancer Policy. 2022Aug22;34:100358. https://doi.org/10.1016/j.jcpo.2022.100358
Yadav UN, Rayamajhee B, Mistry SK, Parsekar SS, Mishra SK. A syndemic perspective on the management of non-communicable diseases amid the covid-19 pandemic in low- and middle-income countries. Frontiers in Public Health. 2020Sep25;8.
Naeem Z. Pakistan – Double burden of diseases. JSTMU 2019; 2(1):1-2. https://doi.org/10.32593/jstmu/Vol 2.Iss1.45
Cuschieri S, Grech S. Insight into the occurrence of common non-communicable diseases at a population level and the potential impact during the coronavirus pandemic — a need for a syndemic healthcare approach? SN Compr. Clin. Med. 2021 Dec22;3(12):2393–400. https://doi.org/10.1007/s42399-021-01064-2
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Taskeen Zahra
This work is licensed under a Creative Commons Attribution 4.0 International License.
The articles published in this journal come under creative commons licence Attribution 4.0 International (CC BY 4.0) which allows to copy and redistribute the material in any medium or format Adapt — remix, transform, and build upon the material for any purpose, even commercially under following terms.
-
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
The editorial board of the Journal strives hard for the authenticity and accuracy of the material published in the Journal. However, findings and statements are views of the authors and do not necessarily represent views of the Editorial Board. Many software like (Google Maps, Google Earth, Biorender (free version)) restricts the free distribution of materials prepared using these softwares. Therefore, authors are strongly advised to check the license/copyright information of the software used to prepare maps/images. In case of publication of copyright material, the correction will be published in one of the subsequent issues of the Journal, and the authors will bear the printing cost.
